Tekla Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Tekla Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-111,768	Closed	-$3.72M	–	229
2020 Q2	$3.72M	Buy	111,768 +20,452	+22%	+$651K	0.14%	121
2020 Q1	$2.48M	Buy	+91,316	New	+$2.54M	0.11%	123
2017 Q4	–	Sell	-152,900	Closed	-$2.83M	–	167
2017 Q3	$2.83M	Hold	152,900	–	–	0.1%	105
2017 Q2	$2.58M	Sell	152,900 -351,500	-70%	-$5.35M	0.1%	105
2017 Q1	$6.73M	Buy	504,400 +197,800	+65%	+$3.1M	0.26%	70
2016 Q4	$4.61M	Buy	306,600 +152,900	+99%	+$2.02M	0.2%	83
2016 Q3	$1.8M	Hold	153,700	–	–	0.07%	122
2016 Q2	$1.66M	Hold	153,700	–	–	0.07%	136
2016 Q1	$1.42M	Hold	153,700	–	–	0.06%	127
2015 Q4	$2.28M	Hold	153,700	–	–	0.08%	118
2015 Q3	$2.52M	Buy	+153,700	New	+$3.15M	0.09%	135
2015 Q2	–	Sell	-353,575	Closed	-$5.37M	–	137
2015 Q1	$5.37M	Sell	353,575 -714,000	-67%	-$9.28M	0.21%	80
2014 Q4	$12.9M	Hold	1,067,575	–	–	0.6%	40
2014 Q3	$12.1M	Buy	1,067,575 +714,100	+202%	+$8.14M	0.57%	38
2014 Q2	$4.27M	Buy	+353,475	New	+$4.18M	0.39%	48

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Tekla Capital Management's MNTA Position: Q3 2020 in Review

Tekla Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 111,768 shares — an estimated $3.72M sold.

Tekla Capital Management first reported a position in MNTA in Q2 2014 and held it in 15 quarters. The position peaked at $12.9M in Q4 2014. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Tekla Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Tekla Capital Management sold 111,768 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $3.72M.
Tekla Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 15 quarters.
Tekla Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $12.9M in Q4 2014.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Tekla Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.